Beam Therapeutics Inc. (NASDAQ:BEAM) Q3 2024 Earnings Call Transcript November 5, 2024
Beam Therapeutics Inc. misses on earnings expectations. Reported EPS is $-1.17 EPS, expectations were $-1.13.
Operator: Good morning, and welcome to the Beam Therapeutics Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Beam’s request. I would now like to turn the call...
